Harel Insurance Investments & Financial Services Ltd. Adma Biologics, Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

  • $6.11 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 18, 2019
SELL
$2.61 - $4.35 $7,830 - $13,049
-3,000 Closed
0 $0
Q3 2018

Oct 29, 2018
BUY
$4.39 - $6.85 $13,169 - $20,550
3,000 New
3,000 $19,000

Others Institutions Holding ADMA

# of Institutions
314
Shares Held
187M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.22B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email